Cargando…
Age Demographics of Subjects Enrolled in Global, Interventional Phase 3 Melanoma Clinical Trials
BACKGROUND: Melanoma is a skin cancer with a rising worldwide incidence of just over 280,000 individuals with the greatest burden of illness in European, New Zealander, and Australian populations. Patients are diagnosed with melanoma with the mean and median ages being 65 and 59 years old, respectiv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854139/ https://www.ncbi.nlm.nih.gov/pubmed/35001359 http://dx.doi.org/10.1007/s43441-021-00362-0 |